Zobrazeno 1 - 8
of 8
pro vyhledávání: '"José González-Llaven"'
Autor:
Cristina Lemini, Aurora García-Manzano, José González-Llaven, Ruth Jaimez, Consuelo Rubio-Póo, Yanira Franco, Ma. Estela Avila
Publikováno v:
Steroids. 67:1129-1135
Oral contraceptives containing estrogens increases the incidence of thromboembolic events. In contrast, administration of 17beta-aminoestrogens prolonged blood clotting time (BCT) in rodents. We studied the effect of estradiol (E(2)), ethinylestradio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39ce33ce5f95091f2e93dc88584aff4
https://doi.org/10.1016/s0039-128x(02)00067-3
https://doi.org/10.1016/s0039-128x(02)00067-3
Autor:
Luis Casanova-Cardiel, José González-Llaven, Eduardo Mateos-García, E Sanchez-Cortés, Jesús Gaytán-Martínez, José Luis Fuentes-Allen
Publikováno v:
Archives of Medical Research. 31:388-392
Background This study was carried out to assess the isolation rate of bacterial and fungal causative agents in Mexican neutropenic adults with hematological neoplasia. Methods A prospective observational survey involving 120 consecutive episodes of f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f4833fcb0ef309fb68baa00a2f6273
https://doi.org/10.1016/s0188-4409(00)00080-1
https://doi.org/10.1016/s0188-4409(00)00080-1
Autor:
Manuel Ayala-Sánchez, F Tripp-Villanueva, A Rosas-Cabral, José González-Llaven, Jaime García-Chávez, Jorge Vela-Ojeda, E Sanchez-Cortés, Miriam García-Ruiz Esparza, Luis David Garcı́a-León
Publikováno v:
Archives of Medical Research. 31:206-209
Background Bone marrow transplantation (BMT) is the therapy of choice for patients with chronic myeloid leukemia (CML) who have a human leukocyte antigen (HLA)-identical donor and are under 50 years of age. Methods Here, 45 patients with CML were tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e738b61543b02cd24b508f8c1afa3fea
https://doi.org/10.1016/s0188-4409(00)00071-0
https://doi.org/10.1016/s0188-4409(00)00071-0
Autor:
F Tripp-Villanueva, A Rosas-Cabral, José González-Llaven, Manuel Ayala-Sánchez, E Sanchez-Cortés, Jorge Vela-Ojeda, M. A. García-Ruiz Esparza
Publikováno v:
Bone Marrow Transplantation. 24:1307-1310
In the present study, we assessed the clinical effect of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in the treatment of refractory, grade III-IV hemorrhagic cystitis (HC) in six patients who underwent bone marrow tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c0ec61910d40330008f9df94fe68306
https://doi.org/10.1038/sj.bmt.1702070
https://doi.org/10.1038/sj.bmt.1702070
Autor:
F Tripp-Villanueva, José González-Llaven, Manuel Ayala-Sánchez, A Rosas-Cabral, E Sanchez-Cortés, Jorge Vela-Ojeda, L Diaz de León, M. A. García-Ruiz Esparza
Publikováno v:
Bone Marrow Transplantation. 24:1029-1031
A 24-year-old woman with CML underwent allogeneic BMT in August 1995 from a one-antigen HLA mismatched brother. Conditioning included BuCy2 and CsA and MTX were used to prevent GVHD. In July 1997 she developed right leg pain, lytic bone lesions of di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f0490d77f65e65ce4cd93ec22acce5
https://doi.org/10.1038/sj.bmt.1701919
https://doi.org/10.1038/sj.bmt.1701919
Autor:
Manuel Ayala-Sánchez, F Tripp-Villanueva, A Rosas-Cabral, M A Esparza, M E Guevara-Moreno, L. D. García-León, E Sanchez-Cortés, Laura Montiel-Cervantes, José González-Llaven, Jorge Vela-Ojeda
Publikováno v:
Bone marrow transplantation. 25(11)
Between August 1994 and June 1999, 56 patients were prospectively randomized to receive ifosfamide 10 g/m2 + GM-CSF 5 microg/kg/day (IFO+GM-CSF n = 28) and cyclophosphamide 4 g/m2 + GM-CSF 5 microg/kg/day (CY+GM-CSF n = 28). Both groups were comparab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::995a963a22eceb6d8a9e76d5e527c02e
https://pubmed.ncbi.nlm.nih.gov/10849526
https://pubmed.ncbi.nlm.nih.gov/10849526
Autor:
Francisco J. Flores-Murrieta, Gilberto Castañeda-Hernández, Jorge Vela-Ojeda, Verónica Brizuela, Rosa Garcı́a-Arreola, José Antonio Palma-Aguirre, Joel Nava-Rangel, Silvia Morán-Lira, José González-Llaven
Publikováno v:
Archives of medical research. 30(4)
Background. The use of conventional cyclosporine (Sandimmune ® ) requires great care, as this drug exhibits a narrow therapeutic index and wide interindividual variability in its pharmacokinetics. Recently, a new microemulsion formulation (Neoral ®
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b755818014f26b1feac28d87fcb360d8
https://pubmed.ncbi.nlm.nih.gov/10573634
https://pubmed.ncbi.nlm.nih.gov/10573634
Autor:
Gilberto Castañeda-Hernández, Francisco J. Flores-Murrieta, José González-Llaven, J. Antonio Palma-Aguirre
Publikováno v:
Journal of clinical pharmacology. 37(7)
The existence of population variations in cyclosporine pharmacokinetics could be expected, as this drug, similar to nifedipine, is biotransformed by cytochrome P-450 subfamily 3A4, and the existence of interethnic variability in nifedipine dispositio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e030703ceb48fde043b4d78dfdeb1b0e
https://pubmed.ncbi.nlm.nih.gov/9243357
https://pubmed.ncbi.nlm.nih.gov/9243357